INSANE: 2 | Rare Historical Photos

Martin Shkreli Amplifies Critique Calling D-Wave's Quantum Tech 'Dead-End:' It Would Take Until 2054 To Match Current Classical Solvers

A critique of D-Wave Quantum Inc. (NYSE:QBTS), amplified by ‘Pharma Bro’ Martin Shkreli, is challenging the company’s viability, alleging its technology is a potential “dead-end.”

Benzinga · Sep 22, 2025

5 Stocks That Dominated Investor Buzz This Week — How OPEN, NVDA, TSLA And Others Performed

Retail investors buzzed about five stocks this week, from Sept. 15 to 19, on platforms like X and Reddit’s r/WallStreetBets, amid market AI enthusiasm and the Federal Reserve rate cuts.

Benzinga · Sep 19, 2025

'Pharma Bro' Martin Shkreli Tells Critics 'Do Not Make Fun of Me' As Opendoor Short Sours Amid Rate-Cut Rally: 'That Is Inappropriate'

Investor Martin Shkreli, popularly known as “Pharma Bro,” pushed back against criticism on this recent short position on iBuying platform Opendoor Technologies Inc. (NASDAQ:OPEN), which is rallying amid the Federal Reserve’s rate cuts on Wednesday.

Benzinga · Sep 18, 2025

Martin Shkreli Is Fighting the Short Squeeze in Newegg Stock. How Should You Play NEGG Here?

The controversial former pharmaceutical executive has declared the stock to be a dud.

Barchart · Aug 25, 2025

'Pharma Bro' CEO Jacked Price of A Life-Saving Drug From $13.50 to $750 Per Pill Overnight — And His Reason? 'We Needed to Turn a Profit'

Imagine needing a medication that costs less than a fast-food meal—only to wake up the next day and find it's suddenly priced like a luxury car payment…per single pill.

Benzinga · Aug 20, 2025

'Pharma Bro' Martin Shkreli Bets Against Soaring Newegg, But Stock Keeps Climbing

Newegg Commerce Inc. (NASDAQ:NEGG) shares skyrocketed over 22% in Wednesday’s session, extending a volatile run that has seen the stock swing dramatically this year. The surge came as the company expanded its stock sale program, addressed issues tied to a shareholder loan foreclosure, and added its chief executive to the…

Benzinga · Aug 20, 2025

'Pharma Bro' Martin Shkreli Shorts Newegg After 1,338% Rally, Calls It 'Close to Worthless'

Former hedge fund manager Martin Shkreli announced on Thursday that he has shorted Newegg Commerce Inc. (NASDAQ:NEGG) following the e-commerce retailer’s massive 1,338% surge this year, dismissing the company as fundamentally overvalued.

Benzinga · Aug 15, 2025

Martin Shkreli Is Shorting This ‘Strong Buy’ Penny Stock. How Should You Play Shares Here?

Martin Shkreli says aTyr stock could crash as much as 80% within the next six weeks. ATYR shares are not particularly attractive even without his warning.

Barchart · Jul 31, 2025

Palantir Touches New All-Time High Before Fading After Hours: What's Going On?

Shares of Palantir Technologies Inc. (NASDAQ:PLTR) surged to a fresh all-time high, despite there being no company-specific news to lead the session.

Benzinga · Jul 24, 2025

'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday

Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge.

Benzinga · Jul 4, 2025